Pfizer Inc. (PFE)
NYSE
Closed
Aug 24, 2026
Day's Range
27.8252 wk Range
23.58Overview - PFE - Pfizer Inc.
Key Statistics
Valuation
Enterprise Value
212.06B
P/E (Trailing)
‪36.93‬
P/E (Forward)
‪9.69‬
PEG Ratio
‪-0.34‬
Price / Sales (TTM)
‪2.51‬
Price / Book
‪1.87‬
EV / EBITDA
‪8.35‬
Profitability
Gross Margin
‪72.78%‬
Profit Margin
‪6.80%‬
Operating Margin
‪27.87%‬
Return on Assets
‪5.78%‬
Return on Equity
‪5.01%‬
Ownership
Shares Outstanding
5.69B
Float
5.69B
Short % of Shares Outstanding
‪2.82%‬
Held by Insiders
‪0.10%‬
Held by Institutions
‪69.13%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪25.36‬
200-Day Avg
‪25.99‬
Dividends
Payout Ratio
‪226.32%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 28.61‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PFE - Pfizer Inc.
Peers - PFE - Pfizer Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
Profile Summary - PFE - Pfizer Inc.
About
Pfizer Inc. is a research-based global biopharmaceutical company founded in 1849 and headquartered in New York. It focuses on the discovery, development, manufacture, marketing, sales, and distribution of biopharmaceutical products worldwide, targeting developed and emerging markets to advance wellness, prevention,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
